Honoring 50 Years of Clinical Heart Transplantation in Circulation-Reference-Cited by-同舟云学术

Honoring 50 Years of Clinical Heart Transplantation in Circulation

Published:2018-01-02 Issue:1 Volume:137 Page:71-87
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Stehlik Josef¹,Kobashigawa Jon²,Hunt Sharon A.³,Reichenspurner Hermann⁴,Kirklin James K.⁵

Affiliation:

1. Division of Cardiovascular Medicine, University of Utah School of Medicine, Salt Lake City (J.S.)

2. Cedars-Sinai Heart Institute, Los Angeles, CA (J.K.)

3. Division of Cardiovascular Medicine, Stanford University, CA (S.A.H.)

4. Department of Cardiovascular Surgery, University Heart Center Hamburg, Germany (H.R.)

5. Division of Cardiothoracic Surgery, University of Alabama at Birmingham (J.K.K.).

Abstract

Heart transplantation has become a standard therapy option for advanced heart failure. The translation of heart transplantation from innovative experiments to long-term clinical success has married prescient insights with discipline and organization in the domains of surgical techniques, organ preservation, immunosuppression, organ donation and transplantation logistics, infection control, and long-term graft surveillance. This review explores the key milestones of the past 50 years of heart transplantation and discusses current challenges and promising innovations on the clinical horizon.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.117.029753

Reference104 articles.

1. The transplantation of veins and organs;Carrel A;Am Med,1905

2. Practical methods of homologous cardiac transplantation.;Webb WR;J Thorac Surg,1959

3. Homologous transplantation of the canine heart.;Golberg M;J Int Coll Surg,1958

Cited by 148 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decellularized extracellular matrix materials for treatment of ischemic cardiomyopathy;Bioactive Materials;2024-03

2. Temporal Trends, Risk Factors, and Clinical Outcomes of De Novo Lymphoproliferative Disorders After Heart Transplantation;JACC: Heart Failure;2024-02

3. Mitochondrion-targeted carboxymethyl chitosan hybrid nanoparticles loaded with Coenzyme Q10 protect cardiac grafts against cold ischaemia‒reperfusion injury in heart transplantation;Journal of Translational Medicine;2023-12-20

4. Ruxolitinib attenuates acute rejection and can serve as an immune induction therapy in heart transplantation;Clinical Immunology;2023-12

5. Unique 40-year survival after heart transplantation with normal graft function and spontaneous operational tolerance;Clinical Research in Cardiology;2023-11-20